top of page

RedHill Biopharma receives patent approval for MS drug

The European Patent Office will grant a new patent covering the use of RedHill Biopharma’s RBH-104, for the treatment of multiple sclerosis (MS).

Click on this link for more information.



Today's News
Follow us
  • LinkedIn Social Icon
  • Vimeo Social Icon
Newsletter on Pharma Legislation
the newsletter of
bottom of page